Table 2.
Cross-reaction and cross neutralization test between bat paramyxovirus (B16-40) and human parainfluenza virus 1 (KBPV-VR-44).
| Viral antigen | Individual Mouse ID | Viruses for Indirect immunofluorescence assaya | Viruses for Serum neutralization assayb | |||
|---|---|---|---|---|---|---|
| Bat Paramyxovirus (B16-40) | Human Parainfluenza virus 1 | Bat Paramyxovirus (B16-40) | Human Parainfluenza virus 1 | |||
| Antiserum | Bat Paramyxovirus (B16-40) |
1 | 80 | NDd | 160 | <10 |
| 2 | 40 | 40 | 160 | <10 | ||
| 3 | 40 | <10 | 160 | <10 | ||
| 4 | 80 | ND | ND | ND | ||
| 5 | <10 | ND | 20 | ND | ||
| 6 | 10 | 10 | 80 | <10 | ||
| Human Parainfluenza virus 1 (KBPV-VR-44) |
1 | 40c | 80 | <10 | 40 | |
| 2 | 20 | <10 | 40 | |||
| 3 | <10 | 20 | <10 | 40 | ||
| 4 | ND | <10 | 40 | |||
| 5 | <10 | 20 | <10 | 160 | ||
| 6 | ND | <10 | 20 | |||
aEnd-point titer was determined to the fluorescent signal in indirect immunofluorescence assay. bEnd-point titer was determined to the inhibition of cytopathic effects in serum neutralization assay. cThe individual mouse sera were pooled. dThe data is not determined.